Gen-Probe Aptima Combo 2 Assay
Dna-Reagents, Neisseria. 510(k) K003395, from Gen-Probe, Inc. (San Diego, CA). Product code LSL, class 2.
As of Nov 22, 2026, K003395 is an FDA 510(k) held by Gen-Probe, Inc., substantially equivalent on May 21, 2001 after 201 days, with 1 recall tied to it in FDA's recall database.
- Review time: 201 days
- Recalls: 1
- Cited as a predicate by: 4 devices
- BD Probetec Neisseria Gonorrhoeae (Gc) Q Amplified Dna AssayK081825 · Becton, Dickinson & CO · Dec 11, 2008
- BD Probetec Chlamydia Trachomatis (Ct) Q Amplified Dna AssayK081824 · Becton, Dickinson & CO · Dec 11, 2008
- Gen-Probe Aptima Combo 2 AssayK043224 · Gen-Probe, Inc. · Aug 9, 2005
- Gen-Probe Aptima Combo 2 AssayK032554 · Gen-Probe, Inc. · Dec 31, 2003
| Started | Recall | Status |
|---|---|---|
| Apr 17, 2014 | Z-1793-2014Incorrect labeling was used on each pouch of the affected lots of APTIMA Urine Specimen Collection Kits. The outer box of the kits are identified correctly as "APTIMA Urine Collection Kits"; however, the inner pouches… | Terminated |
- Aptima Neisseria gonorrhoeae AssayK231329 · Hologic, Inc. · Jan 26, 2024
- Type
- Traditional
- Received
- Nov 1, 2000
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3390
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files